First Horizon: 3 Key Takeaways for Long-Term Investors

First Horizon agreed to sell about $4.5 billion of low-yielding residential mortgage loans, with management projecting roughly 4% EPS accretion and approximately 150 basis points of improved ROTCE in 2027. The bank said share buybacks will resume in Q4 while maintaining its CET1 targets; executives also reported quarterly client deposit growth of more than $1 billion and NIM of 3.48%. The repositioning is intended to free capacity for higher-yielding commercial lending.

Analysis

The thesis is a capital-allocation test, not yet a durable earnings rerating. Mortgage runoff only creates value if First Horizon redeploys the released capacity into relationship loans at returns that exceed the foregone asset yield after funding, operating, credit, and capital costs. The projected 2027 EPS benefit is management guidance; sale economics, timing, and actual loan deployment remain unverified. A sale discount or a lag before new lending ramps could dilute near-term earnings despite the stated accretion.

The second-order risk is mix: replacing relatively simple mortgage exposure with commercial lending may improve yield but increase credit-cycle sensitivity and capital consumption. Relationship deposits can offset wholesale funding pressure, but deposit growth is valuable only if pricing stays disciplined; competitors bidding for commercial relationships could erode that advantage.

Over the next few weeks, buyback resumption may support sentiment, but it is not proof of improved underlying returns. Over 1–3 months, watch transaction completion, sale proceeds versus carrying value, and loan deployment. Over 6–18 months, the key test is whether commercial growth lifts returns without deterioration in credit costs or deposit pricing. The contrarian point: the market may over-credit the EPS accretion headline while underweighting execution lag and credit-mix risk. Conversely, evidence of prompt, profitable deployment could make the 2027 benefit more durable than the headline alone implies.

Key Decisions for Investors

• Do not chase the announcement as a standalone catalyst. Consider a small relative long FHN versus a regional-bank basket only after the sale closes without material loss and subsequent disclosures show commercial balances absorbing capacity; the upside is execution of the stated earnings and return improvement, while the principal risk is lower-yielding assets leaving before profitable loans arrive.
• Treat the Q4 buyback as a secondary catalyst, not the core thesis. Verify CET1 remains within management’s target and confirm the repurchase is not substituting for weak organic growth; pause the trade if capital ratios or credit trends weaken.
• Track sale price versus carrying value, redeployment timing and yields, commercial loan growth, deposit costs, and credit provisions. Falsify the thesis if NIM weakens materially, deposit pricing accelerates, commercial lending fails to replace runoff, or credit costs rise enough to offset the projected 2027 accretion.